ReP USP - Resultado da busca

Artigo de periodico
Predicting obsessive–compulsive disorder severity combining neuroimaging and machine learning methods (2013)
Hoexter, Marcelo Q.; Miguel, Euripedes C.; Diniz, Juliana B.; Shavitt, Roseli G.; Busatto, Geraldo F.; Sato, João R.
Source: Journal of Affective Disorders. Unidade: FM
Subjects: TRANSTORNO OBSESSIVO-COMPULSIVO, IMAGEM POR RESSONÂNCIA MAGNÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOEXTER, Marcelo Q. et al. Predicting obsessive–compulsive disorder severity combining neuroimaging and machine learning methods. Journal of Affective Disorders, v. 150, n. 3, p. 1213-1216, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.jad.2013.05.041. Acesso em: 14 nov. 2024.
APA
Hoexter, M. Q., Miguel, E. C., Diniz, J. B., Shavitt, R. G., Busatto, G. F., & Sato, J. R. (2013). Predicting obsessive–compulsive disorder severity combining neuroimaging and machine learning methods. Journal of Affective Disorders, 150( 3), 1213-1216. doi:10.1016/j.jad.2013.05.041
NLM
Hoexter MQ, Miguel EC, Diniz JB, Shavitt RG, Busatto GF, Sato JR. Predicting obsessive–compulsive disorder severity combining neuroimaging and machine learning methods [Internet]. Journal of Affective Disorders. 2013 ; 150( 3): 1213-1216.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.jad.2013.05.041
Vancouver
Hoexter MQ, Miguel EC, Diniz JB, Shavitt RG, Busatto GF, Sato JR. Predicting obsessive–compulsive disorder severity combining neuroimaging and machine learning methods [Internet]. Journal of Affective Disorders. 2013 ; 150( 3): 1213-1216.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.jad.2013.05.041
Artigo de periodico-carta/editorial
Antipsychotic drugs decrease iPLA2 gene expression in schizophrenia [Carta] (2013)
Kerr, Daniel Shikanai; Talib, Leda Leme; Yamamoto, Victor Junji; Ferreira, Aline S.; Zanetti, Marcus V.; Serpa, Mauricio H.; Busatto, Geraldo F.; Van de Bilt, Martinus Theodorus; Gattaz, Wagner Farid
Source: Schizophrenia research. Unidade: FM
Subjects: ANTIPSICÓTICOS (APLICAÇÕES TERAPÊUTICAS), ESQUIZOFRENIA (TERAPIA), ANTIPSICÓTICOS (USO TERAPÊUTICO), FOSFOLIPASES A
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KERR, Daniel Shikanai et al. Antipsychotic drugs decrease iPLA2 gene expression in schizophrenia [Carta]. Schizophrenia research. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/j.schres.2013.03.026. Acesso em: 14 nov. 2024. , 2013
APA
Kerr, D. S., Talib, L. L., Yamamoto, V. J., Ferreira, A. S., Zanetti, M. V., Serpa, M. H., et al. (2013). Antipsychotic drugs decrease iPLA2 gene expression in schizophrenia [Carta]. Schizophrenia research. Amsterdam: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/j.schres.2013.03.026
NLM
Kerr DS, Talib LL, Yamamoto VJ, Ferreira AS, Zanetti MV, Serpa MH, Busatto GF, Van de Bilt MT, Gattaz WF. Antipsychotic drugs decrease iPLA2 gene expression in schizophrenia [Carta] [Internet]. Schizophrenia research. 2013 ; 147( 1): 203-204.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.schres.2013.03.026
Vancouver
Kerr DS, Talib LL, Yamamoto VJ, Ferreira AS, Zanetti MV, Serpa MH, Busatto GF, Van de Bilt MT, Gattaz WF. Antipsychotic drugs decrease iPLA2 gene expression in schizophrenia [Carta] [Internet]. Schizophrenia research. 2013 ; 147( 1): 203-204.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.schres.2013.03.026
Trabalho de evento-resumo periodico
Pretreatment Orbitofrontal Thickness as a Measure to Classify OCD Patients in Responders and Non-Responders (2013)
Hoexter, Marcelo Q.; Lopes, Antonio C.; Shavitt, Roseli G.; Batistuzzo, Marcelo C.; Dougherty, Darin D.; Diniz, Juliana B.; Duran, Fabio F. S.; Busatto, Geraldo F.; Bressan, Rodrigo A.; Sato, João R.; Miguel, Euripedes C.
Source: Biological psychiatry. Conference titles: Annual Scientific Convention and Meeting. Unidade: FM
Subjects: TRANSTORNO OBSESSIVO-COMPULSIVO (TERAPIA), IMAGEM POR RESSONÂNCIA MAGNÉTICA, CÓRTEX PRÉ-FRONTAL, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOEXTER, Marcelo Q. et al. Pretreatment Orbitofrontal Thickness as a Measure to Classify OCD Patients in Responders and Non-Responders. Biological psychiatry. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/S0006-3223(13)00287-4. Acesso em: 14 nov. 2024. , 2013
APA
Hoexter, M. Q., Lopes, A. C., Shavitt, R. G., Batistuzzo, M. C., Dougherty, D. D., Diniz, J. B., et al. (2013). Pretreatment Orbitofrontal Thickness as a Measure to Classify OCD Patients in Responders and Non-Responders. Biological psychiatry. New York: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/S0006-3223(13)00287-4
NLM
Hoexter MQ, Lopes AC, Shavitt RG, Batistuzzo MC, Dougherty DD, Diniz JB, Duran FFS, Busatto GF, Bressan RA, Sato JR, Miguel EC. Pretreatment Orbitofrontal Thickness as a Measure to Classify OCD Patients in Responders and Non-Responders [Internet]. Biological psychiatry. 2013 ; 73( 9): 78S.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/S0006-3223(13)00287-4
Vancouver
Hoexter MQ, Lopes AC, Shavitt RG, Batistuzzo MC, Dougherty DD, Diniz JB, Duran FFS, Busatto GF, Bressan RA, Sato JR, Miguel EC. Pretreatment Orbitofrontal Thickness as a Measure to Classify OCD Patients in Responders and Non-Responders [Internet]. Biological psychiatry. 2013 ; 73( 9): 78S.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/S0006-3223(13)00287-4
Artigo de periodico
Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive–compulsive disorder (2013)
Hoexter, Marcelo Q.; Dougherty, Darin D.; Duran, Fabio L. S.; Lopes, Antonio C.; Diniz, Juliana B.; Batistuzzo, Marcelo C.; Evans, Karleyton C.; Bressan, Rodrigo A.; Busatto, Geraldo F.; Miguel, Euripedes C.
Source: European Neuropsychopharmacology. Unidade: FM
Subjects: TERAPIA COMPORTAMENTAL, TERAPIA COGNITIVA, TRANSTORNO OBSESSIVO-COMPULSIVO (TERAPIA), RECEPTORES DE SEROTONINA, ANTIDEPRESSIVOS (USO TERAPÊUTICO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HOEXTER, Marcelo Q. et al. Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive–compulsive disorder. European Neuropsychopharmacology, v. 23, n. 7, p. 569-580, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.euroneuro.2012.06.014. Acesso em: 14 nov. 2024.
APA
Hoexter, M. Q., Dougherty, D. D., Duran, F. L. S., Lopes, A. C., Diniz, J. B., Batistuzzo, M. C., et al. (2013). Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive–compulsive disorder. European Neuropsychopharmacology, 23( 7), 569-580. doi:10.1016/j.euroneuro.2012.06.014
NLM
Hoexter MQ, Dougherty DD, Duran FLS, Lopes AC, Diniz JB, Batistuzzo MC, Evans KC, Bressan RA, Busatto GF, Miguel EC. Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive–compulsive disorder [Internet]. European Neuropsychopharmacology. 2013 ; 23( 7): 569-580.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.euroneuro.2012.06.014
Vancouver
Hoexter MQ, Dougherty DD, Duran FLS, Lopes AC, Diniz JB, Batistuzzo MC, Evans KC, Bressan RA, Busatto GF, Miguel EC. Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive–compulsive disorder [Internet]. European Neuropsychopharmacology. 2013 ; 23( 7): 569-580.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.euroneuro.2012.06.014
Artigo de periodico
Resting-state functional connectivity in normal brain aging (2013)
Ferreira, Luiz Kobuti; Busatto, Geraldo F.
Source: Neuroscience and Biobehavioral Reviews. Unidade: FM
Subjects: IDOSOS, ENVELHECIMENTO, ATENÇÃO, IMAGEM POR RESSONÂNCIA MAGNÉTICA, COGNIÇÃO, MEMÓRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Luiz Kobuti e BUSATTO, Geraldo F. Resting-state functional connectivity in normal brain aging. Neuroscience and Biobehavioral Reviews, v. 37, n. 3, p. 384-400, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.neubiorev.2013.01.017. Acesso em: 14 nov. 2024.
APA
Ferreira, L. K., & Busatto, G. F. (2013). Resting-state functional connectivity in normal brain aging. Neuroscience and Biobehavioral Reviews, 37( 3), 384-400. doi:10.1016/j.neubiorev.2013.01.017
NLM
Ferreira LK, Busatto GF. Resting-state functional connectivity in normal brain aging [Internet]. Neuroscience and Biobehavioral Reviews. 2013 ; 37( 3): 384-400.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.neubiorev.2013.01.017
Vancouver
Ferreira LK, Busatto GF. Resting-state functional connectivity in normal brain aging [Internet]. Neuroscience and Biobehavioral Reviews. 2013 ; 37( 3): 384-400.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.neubiorev.2013.01.017
Trabalho de evento-resumo periodico
Increased GDNF but not BDNF Plasma Levels in Type II Compared to Type I Bipolar Disorder (2013)
Zanetti, Marcus V.; Teixeira, Antonio L.; Chaim, Tiffany M.; Sousa, Rafael T. de; Talib, Leda L.; Gattaz, Wagenr F.; Busatto, Geraldo F.; Machado-Vieira, Rodrigo
Source: Biological psychiatry. Conference titles: Annual Scientific Convention and Meeting. Unidade: FM
Subjects: TRANSTORNO BIPOLAR (DIAGNÓSTICO), PLASMA (NÍVEL), RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZANETTI, Marcus V. et al. Increased GDNF but not BDNF Plasma Levels in Type II Compared to Type I Bipolar Disorder. Biological psychiatry. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/S0006-3223(13)00288-6. Acesso em: 14 nov. 2024. , 2013
APA
Zanetti, M. V., Teixeira, A. L., Chaim, T. M., Sousa, R. T. de, Talib, L. L., Gattaz, W. F., et al. (2013). Increased GDNF but not BDNF Plasma Levels in Type II Compared to Type I Bipolar Disorder. Biological psychiatry. New York: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/S0006-3223(13)00288-6
NLM
Zanetti MV, Teixeira AL, Chaim TM, Sousa RT de, Talib LL, Gattaz WF, Busatto GF, Machado-Vieira R. Increased GDNF but not BDNF Plasma Levels in Type II Compared to Type I Bipolar Disorder [Internet]. Biological psychiatry. 2013 ; 73( 9): 152S.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/S0006-3223(13)00288-6
Vancouver
Zanetti MV, Teixeira AL, Chaim TM, Sousa RT de, Talib LL, Gattaz WF, Busatto GF, Machado-Vieira R. Increased GDNF but not BDNF Plasma Levels in Type II Compared to Type I Bipolar Disorder [Internet]. Biological psychiatry. 2013 ; 73( 9): 152S.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/S0006-3223(13)00288-6
Trabalho de evento-resumo periodico
Increased Lactate Levels During Depressive Episodes and Reversal Effects by Lithium Monotherapy in Subjects with Bipolar Disorder (2013)
Machado-Vieira, Rodrigo; Zanetti, Marcus V.; Otaduy, Maria C. G.; Sousa, Rafael T. de; Costa, Alana C.; Chaim, Tiffany M.; Leite, Claudia C.; Busatto, Geraldo F.; Gattaz, Wagner F.
Source: Biological psychiatry. Conference titles: Annual Scientific Convention and Meeting. Unidade: FM
Subjects: ESPECTROSCOPIA, LÍTIO (USO TERAPÊUTICO), DEPRESSÃO (TERAPIA), TRANSTORNO BIPOLAR, LACTATOS, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO-VIEIRA, Rodrigo et al. Increased Lactate Levels During Depressive Episodes and Reversal Effects by Lithium Monotherapy in Subjects with Bipolar Disorder. Biological psychiatry. New York: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1016/S0006-3223(13)00289-8. Acesso em: 14 nov. 2024. , 2013
APA
Machado-Vieira, R., Zanetti, M. V., Otaduy, M. C. G., Sousa, R. T. de, Costa, A. C., Chaim, T. M., et al. (2013). Increased Lactate Levels During Depressive Episodes and Reversal Effects by Lithium Monotherapy in Subjects with Bipolar Disorder. Biological psychiatry. New York: Faculdade de Medicina, Universidade de São Paulo. doi:10.1016/S0006-3223(13)00289-8
NLM
Machado-Vieira R, Zanetti MV, Otaduy MCG, Sousa RT de, Costa AC, Chaim TM, Leite CC, Busatto GF, Gattaz WF. Increased Lactate Levels During Depressive Episodes and Reversal Effects by Lithium Monotherapy in Subjects with Bipolar Disorder [Internet]. Biological psychiatry. 2013 ; 73( 9): 238S.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/S0006-3223(13)00289-8
Vancouver
Machado-Vieira R, Zanetti MV, Otaduy MCG, Sousa RT de, Costa AC, Chaim TM, Leite CC, Busatto GF, Gattaz WF. Increased Lactate Levels During Depressive Episodes and Reversal Effects by Lithium Monotherapy in Subjects with Bipolar Disorder [Internet]. Biological psychiatry. 2013 ; 73( 9): 238S.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/S0006-3223(13)00289-8

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em